Compounds > androstane-3,17-diol
Page last updated: 2024-08-23

androstane-3,17-diol and Breast Neoplasms

androstane-3,17-diol has been researched along with Breast Neoplasms in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-199011 (57.89)18.7374
1990's2 (10.53)18.2507
2000's2 (10.53)29.6817
2010's4 (21.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gohno, T; Hanamura, T; Hayashi, S; Ito, K; Kobayashi, Y; Konno, H; Kurosumi, M; Nishikawa, S; Niwa, T; Takei, H; Tazawa, C; Yamaguchi, Y1
Cordero, KE; Johnson, MD; Larios, JM; Lippman, ME; Rae, JM; Sikora, MJ1
Lundqvist, J; Norlin, M; Pettersson, H1
Doillon, C; Jegham, H; Maltais, R; Poirier, D; Roy, J1
Häring, J; Lattrich, C; Ortmann, O; Schüler, S; Stegerer, A; Treeck, O1
Borja-Cacho, E; Damián-Matsumura, P; García-Becerra, R; González, L; Larrea, F; Lemus, AE; Pérez-Palacios, G; Santillán, R1
Blaustein, A; Levitz, M; Raju, U1
Berrino, F; Decarli, A; Di Pietro, S; Fariselli, G; Recchione, C; Secreto, G; Toniolo, P1
Castagnola, G; Di Fronzo, G; Oriana, S; Preda, F; Scavone, G; Secreto, G; Severini, A1
Cavalleri, A; Grignolio, E; Recchione, C; Secreto, G1
Bandieramonte, G; Dati, V; Di Pietro, S; Fariselli, G; Recchione, C; Secreto, G1
Forrest, AP; Hawkins, RA; Miller, WR1
Filmer, A; Hackenberg, R; Schulz, KD; Turgetto, I1
Hackenberg, R; Schulz, KD1
Abul-Hajj, YJ1
Forrest, AP; Miller, WR; Shivas, AA1
Gratterola, R1
Poortman, J; Schwarz, F; Thijssen, JH; Vroegindewey-Jie, D1
Forrest, AP; Miller, WR1

Reviews

1 review(s) available for androstane-3,17-diol and Breast Neoplasms

ArticleYear
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N

    Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured

1996

Other Studies

18 other study(ies) available for androstane-3,17-diol and Breast Neoplasms

ArticleYear
Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Breast cancer research and treatment, 2013, Volume: 139, Issue:3

    Topics: Androgens; Androstane-3,17-diol; Aromatase Inhibitors; Breast Neoplasms; Dihydrotestosterone; Drug Resistance, Neoplasm; Female; Green Fluorescent Proteins; Humans; Letrozole; MCF-7 Cells; Multienzyme Complexes; Nitriles; Progesterone Reductase; Receptors, Androgen; Receptors, Estrogen; Response Elements; Signal Transduction; Steroid Isomerases; Testosterone; Triazoles

2013
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
    Breast cancer research and treatment, 2009, Volume: 115, Issue:2

    Topics: Androgens; Androstane-3,17-diol; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Humans; Reverse Transcriptase Polymerase Chain Reaction

2009
Effects of CYP7B1-mediated catalysis on estrogen receptor activation.
    Biochimica et biophysica acta, 2010, Volume: 1801, Issue:9

    Topics: Adjuvants, Immunologic; Anabolic Agents; Androstane-3,17-diol; Animals; Blotting, Western; Breast Neoplasms; Catalysis; Cells, Cultured; Cytochrome P450 Family 7; Dehydroepiandrosterone; Estrogen Receptor alpha; Estrogen Receptor beta; Exonucleases; Exoribonucleases; Humans; Kidney; Luciferases; Microsomes, Liver; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid Hydroxylases; Swine

2010
Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines.
    Anti-cancer drugs, 2012, Volume: 23, Issue:8

    Topics: Androstane-3,17-diol; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Female; G1 Phase; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Resting Phase, Cell Cycle; Xenograft Model Antitumor Assays

2012
Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
    Steroids, 2013, Volume: 78, Issue:2

    Topics: Alternative Splicing; Androstane-3,17-diol; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Dose-Response Relationship, Drug; Estrogen Receptor beta; Female; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Time Factors

2013
Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    The Journal of endocrinology, 2006, Volume: 190, Issue:3

    Topics: Analysis of Variance; Androgens; Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Carbon Isotopes; Cell Line, Tumor; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression Profiling; HeLa Cells; Humans; Isotope Labeling; Testosterone; Transcriptional Activation; Transfection

2006
Conjugation of androgens and estrogens by human breast tumors in vitro.
    Steroids, 1980, Volume: 35, Issue:6

    Topics: Adult; Aged; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Estriol; Estrogens; Female; Humans; Middle Aged; Receptors, Estrogen; Testosterone

1980
Increased androgenic activity and breast cancer risk in premenopausal women.
    Cancer research, 1984, Volume: 44, Issue:12 Pt 1

    Topics: Androgens; Androstane-3,17-diol; Breast Neoplasms; Female; Humans; Menopause; Progesterone; Reference Values; Risk; Testosterone

1984
Long-term response to ovariectomy in 35 premenopausal patients with advanced breast cancer, treated in coherence with hormonal tests.
    Tumori, 1983, Aug-31, Volume: 69, Issue:4

    Topics: Androstane-3,17-diol; Androstanols; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Female; Humans; Postoperative Care; Receptors, Estrogen; Testosterone

1983
Increased urinary androgen excretion is a hormonal abnormality detectable before the clinical onset of breast cancer.
    Cancer detection and prevention, 1983, Volume: 6, Issue:4-5

    Topics: Adult; Age Factors; Androstane-3,17-diol; Androstanols; Breast Neoplasms; Female; Humans; Middle Aged; Parity; Risk; Testosterone; Time Factors

1983
Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:1

    Topics: Adult; Androstane-3,17-diol; Androstanols; Breast; Breast Neoplasms; Epithelium; Female; Humans; Hyperplasia; Middle Aged; Risk; Testosterone

1983
Steroid metabolism and oestrogen receptors in human breast carcinomas.
    European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:8

    Topics: Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Humans; Menopause; Receptors, Estrogen; Testosterone

1981
Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 46, Issue:5

    Topics: Androstane-3,17-diol; Androstenediol; Binding, Competitive; Breast Neoplasms; Cell Division; Female; Humans; Metribolone; Receptors, Androgen; Receptors, Estrogen; Tumor Cells, Cultured

1993
Metabolism of dehydroepiandrosterone by hormone dependent and hormone independent human breast carcinoma.
    Steroids, 1975, Volume: 26, Issue:4

    Topics: Androstane-3,17-diol; Androstanes; Binding Sites; Breast Neoplasms; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Female; Humans; In Vitro Techniques; Kinetics; Protein Binding; Receptors, Cell Surface; Testosterone

1975
Factors affecting testosterone metabolism by human breast tissues.
    Clinical oncology, 1978, Volume: 4, Issue:1

    Topics: Androstane-3,17-diol; Androstenedione; Breast; Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Humans; In Vitro Techniques; Menopause; Testosterone

1978
Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
    Cancer research, 1978, Volume: 38, Issue:9

    Topics: Adult; Androstane-3,17-diol; Androstanes; Anovulation; Breast Diseases; Breast Neoplasms; Cysts; Endometrial Hyperplasia; Female; Humans; Luteal Phase; Middle Aged; Risk; Testosterone

1978
Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue.
    Molecular and cellular endocrinology, 1977, Volume: 8, Issue:1

    Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Myometrium; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship; Testosterone; Uterine Neoplasms

1977
Oestradiol synthesis from C19 steroids by human breast cancers.
    British journal of cancer, 1976, Volume: 33, Issue:1

    Topics: Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Dihydrotestosterone; Estradiol; Humans; In Vitro Techniques; Testosterone

1976